Literature DB >> 23041450

Comparison of the performance of IFA, CFA, and ELISA assays for the serodiagnosis of acute Q fever by quality assessment.

Tineke Herremans1, Boris M Hogema, Marrigje Nabuurs, Marcel Peeters, Marjolijn Wegdam-Blans, Peter Schneeberger, Carla Nijhuis, Daan W Notermans, Joep Galama, Anton Horrevorts, Inge H M van Loo, Bart Vlaminckx, Hans L Zaaijer, Marion P Koopmans, Hanneke Berkhout, Cristina Socolovschi, Didier Raoult, John Stenos, William Nicholson, Henk Bijlmer.   

Abstract

The indirect immunofluorescence assay (IFA) is considered the reference method for diagnosing Q fever, but serology is also performed by complement fixation assay (CFA) or enzyme-linked immunosorbent assay (ELISA). However, comparability between these assays is not clear, and therefore a quality assessment was performed. A total of 25 serum samples from negative controls, Q fever patients, and a serial diluted high-positive sample were analyzed in 10 Dutch laboratories. Six laboratories performed CFA, 5 performed IFA, and 5 performed ELISAs. Three international reference laboratories from Australia, France, and the USA also participated in this study. Qualitative values between laboratories using the same methods were within close range, and all 3 methods correctly identified acute Q fever patients. The IFA, ELISA, and CFA are all suitable serodiagnostic assays to diagnose acute Q fever, but the IFA remains an important tool in the follow-up of patients and in identifying patients at risk for developing chronic Q fever.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23041450     DOI: 10.1016/j.diagmicrobio.2012.09.001

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  14 in total

1.  Comparison of Different Commercially Available Enzyme-Linked Immunosorbent Assays with Immunofluorescence Test for Detection of Phase II IgG and IgM Antibodies to Coxiella burnetii.

Authors:  Larissa Dangel; Daniela Koempf; Silke F Fischer
Journal:  J Clin Microbiol       Date:  2020-01-28       Impact factor: 5.948

2.  Prevalence of Coxiella burnetii Infection in Humans Occupationally Exposed to Animals in Poland.

Authors:  Monika Szymańska-Czerwińska; Elżbieta Monika Galińska; Krzysztof Niemczuk; Józef Piotr Knap
Journal:  Vector Borne Zoonotic Dis       Date:  2015-04       Impact factor: 2.133

3.  Screening of post-mortem tissue donors for Coxiella burnetii infection after large outbreaks of Q fever in The Netherlands.

Authors:  Marja J van Wijk; D Willemijn Maas; Nicole Hm Renders; Mirjam H A Hermans; Hans L Zaaijer; Boris M Hogema
Journal:  BMC Infect Dis       Date:  2014-01-06       Impact factor: 3.090

4.  Specific in vitro interferon-gamma and IL-2 production as biomarkers during treatment of chronic Q fever.

Authors:  Teske Schoffelen; Marjolijn C Wegdam-Blans; Anne Ammerdorffer; Marjolijn J H Pronk; Yvonne E P Soethoudt; Mihai G Netea; Jos W M van der Meer; Chantal P Bleeker-Rovers; Marcel van Deuren
Journal:  Front Microbiol       Date:  2015-02-12       Impact factor: 5.640

5.  Unreliability of three commercial Coxiella burnetii phase II IgM ELISA kits for the seroscreening of acute Q fever in human cases.

Authors:  Selvaraj Stephen; Stanley Ambroise; Jothimani Pradeep; Dhandapany Gunasekaran; Balakrishnan Sangeetha; Kengamuthu Sarangapani
Journal:  Indian J Med Res       Date:  2017-09       Impact factor: 2.375

6.  Acute Q fever in febrile patients in northwestern of Iran.

Authors:  Saber Esmaeili; Farhad Golzar; Erfan Ayubi; Behrooz Naghili; Ehsan Mostafavi
Journal:  PLoS Negl Trop Dis       Date:  2017-04-10

7.  Notification data and criteria during a large Q-fever epidemic reassessed.

Authors:  D A T Hanssen; G Morroy; M M A de Lange; C C H Wielders; W van der Hoek; F Dijkstra; P M Schneeberger
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

8.  A cross-sectional study to assess the long-term health status of patients with lower respiratory tract infections, including Q fever.

Authors:  A S G van Dam; J A F van Loenhout; J B Peters; A Rietveld; W J Paget; R P Akkermans; A Olde Loohuis; J L A Hautvast; J van der Velden
Journal:  Epidemiol Infect       Date:  2014-03-14       Impact factor: 4.434

9.  Human dose response relation for airborne exposure to Coxiella burnetii.

Authors:  Russell John Brooke; Mirjam E E Kretzschmar; Nico T Mutters; Peter F Teunis
Journal:  BMC Infect Dis       Date:  2013-10-21       Impact factor: 3.090

10.  Chronic Q Fever in Alberta: A Case of Coxiella burnetii Mycotic Aneurysm and Concomitant Vertebral Osteomyelitis.

Authors:  William Stokes; Jack Janvier; Stephen Vaughan
Journal:  Can J Infect Dis Med Microbiol       Date:  2016-05-11       Impact factor: 2.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.